Ark Biotech
New York, US · Founded 2021 · Delaware corporation · 1 known investors
AI-powered software for optimizing biopharma manufacturing
Founders & leadership
IF
Irving FainDirector
YA
Yosef A QuintExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$8.2MraisedMay 2024 · 8 investors · Other TechnologyRule 506(b)
▶$8.2MraisedMay 2024 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yosef Avraham QuintExecutive Officer, Director
- Irving FainDirector
- Offering amount
- $11M
- Amount sold
- $8.2M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedOct 2022 · 5 investors · Other TechnologyRule 506(b)
▶$5MraisedOct 2022 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yosef Avraham QuintExecutive Officer, Director
- Irving FainDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6MraisedMay 2022 · 12 investors · Other TechnologyRule 506(b)
▶$6MraisedMay 2022 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Irving FainDirector
- Yosef Avraham QuintExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MraisedDec 2021 · 10 investors · Other TechnologyRule 506(c)
▶$2.5MraisedDec 2021 · 10 investors · Other Technology
Rule 506(c)Officers, directors & promoters on the filing
- Irving FainDirector
- Yosef A QuintExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $10K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.